Does retatrutide lose effectiveness over time?

This site holds no citation on individual loss of effect or on a date when retatrutide fades. What it holds is trial windows: TRIUMPH-1 randomized 2,339 people and a company release reported up to 28.3% mean weight loss at 80 weeks on 12 milligrams versus 2.2% on placebo; Phase 2 ran 48 weeks in 338 adults, up to 24.2% at 12 milligrams. Those are averages over a set window. Retatrutide remains investigational. A research-chemical vial is not the trial product. Missed doses and diet changes are still the first non-drug questions a clinician would ask. This FAQ does not invent a fade clock. Full record at /compounds/retatrutide.

Educational use only. This database summarizes published research and is not medical advice. Where a dose appears it is a record of what a trial or clinic ran, or what people describe doing, with its source attached. Nothing here is a recommendation for personal use.

Part of glp-1 and metabolic peptides. Semaglutide, tirzepatide, retatrutide, and the rest of the incretin and glucagon receptor family.